You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gemcitabine

Showing 51 - 75 of 1,157
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Tumors Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Pancreatic Neoplasms
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Aug 10, 2022

Urothelial Carcinoma Bladder, PD-1 Inhibitor Trial in Shanghai (Tislelizumab, Gemcitabine, Cisplatin)

Recruiting
  • Urothelial Carcinoma Bladder
  • PD-1 Inhibitor
  • Shanghai, Shanghai, China
    Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Aug 15, 2022

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Carboplatin)

Recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
  • Kuala Lumpur, Malaysia
    University Malaya Medical Centre
Nov 1, 2022

Malignant Tumor of Bone and Articular Cartilage, Malignant Tumors of Female Genital Organs, Malignant Tumors of Independent

Recruiting
  • Malignant Neoplasm of Bone and Articular Cartilage
  • +9 more
  • Gemcitabine
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Oct 26, 2022

Advanced Urothelial Carcinoma Trial in Bern (Magrolimab, Cisplatin, Gemcitabine)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Bern, Switzerland
    University Hospital Insel
Feb 20, 2023

Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • Gemcitabine
  • +2 more
  • (no location specified)
Sep 9, 2022

Non Small Cell Lung Cancer, NSCLC, Small-cell Lung Cancer Trial in Saint Louis (ADI-PEG 20, Gemcitabine, Docetaxel)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • ADI-PEG 20
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 14, 2022

Sarcoma Trial in Santa Monica (Gemcitabine, Doxorubicin, Docetaxel)

Recruiting
  • Sarcoma
  • Gemcitabine
  • +3 more
  • Santa Monica, California
    Sant P Chawla
May 4, 2022

Metastatic HER2-Positive Breast Cancer Trial in United States (Gemcitabine, Trastuzumab, Pertuzumab)

Active, not recruiting
  • Metastatic HER2-Positive Breast Cancer
  • Gemcitabine
  • +2 more
  • Hartford, Connecticut
  • +4 more
Dec 1, 2022

Pancreatic Cancer Stage IV, Chemo-induced Nausea and Vomiting Trial (Thalidomide, Nab paclitaxel, Gemcitabine)

Not yet recruiting
  • Pancreatic Cancer Stage IV
  • Chemotherapy-induced Nausea and Vomiting
  • (no location specified)
Aug 24, 2023

Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)

Not yet recruiting
  • Bile Duct Cancer
  • +4 more
  • Gemcitabine
  • +3 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 23, 2023

Pancreatic Cancer Trial in Baltimore, Dallas (ARQ-761, Gemcitabine, nab-paclitaxel)

Terminated
  • Pancreatic Cancer
  • Baltimore, Maryland
  • +1 more
May 31, 2022

Intrahepatic Cholangiocarcinoma Trial (procedure, drug, biological)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Biopsy
  • +7 more
  • (no location specified)
Sep 21, 2023

Testicular Cancer Trial in Houston, Seattle (Gemcitabine, Docetaxel, Melphalan)

Active, not recruiting
  • Testicular Cancer
  • Gemcitabine
  • +7 more
  • Houston, Texas
  • +1 more
Dec 5, 2022

Biliary Tract Cancer, Cholangiocarcinoma Trial in Italy (Gemcitabine, Nab paclitaxel, Cisplatin)

Not yet recruiting
  • Biliary Tract Cancer
  • Cholangiocarcinoma
  • Gemcitabine
  • +4 more
  • Ancona, Italy
  • +18 more
Sep 16, 2023

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Beverly Hills, Los Angeles

Recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Gemcitabine
  • +2 more
  • Beverly Hills, California
  • +1 more
Jun 16, 2022

Resectable Cholangiocarcinoma, Stage IB Intrahepatic Cholangiocarcinoma AJCC v8, Stage II Intrahepatic Cholangiocarcinoma AJCC

Active, not recruiting
  • Resectable Cholangiocarcinoma
  • +5 more
  • Atlanta, Georgia
  • +6 more
Oct 5, 2022

Mature T-Cell and NK-Cell Tumor Trial in Hwasun-gun (Copanlisib, Gemcitabine)

Completed
  • Mature T-Cell and NK-Cell Neoplasm
  • Hwasun-gun, Jeollanam-do, Korea, Republic of
    Chonnam National University Hwasun Hospital
Jun 9, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (QL1706, Carrelizumab, Gemcitabine)

Recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangzhou, China
    Sun Yat-sen University Cancer Center
Oct 21, 2022

Advanced Breast Cancer Trial in Spain (Pembrolizumab, Gemcitabine)

Completed
Has Results
  • Advanced Breast Cancer
  • Badalona, Barcelona, Spain
  • +8 more
Apr 12, 2022

Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitors Trial (Cadonilimab, Gemcitabine, Cisplatin)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Immune Checkpoint Inhibitors
  • (no location specified)
Jun 1, 2023

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Adenocarcinoma Trial in New York, Providence (Motixafortide, Cemiplimab,

Recruiting
  • Pancreatic Cancer
  • +2 more
  • New York, New York
  • +1 more
Nov 7, 2022

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in Columbus (procedure, drug, biological)

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • HER2-Negative Breast Carcinoma
  • Biospecimen Collection
  • +5 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 30, 2023

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

Active, not recruiting
  • Brain Tumor
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 20, 2022

Metastatic Pancreatic Adenocarcinoma Trial in France (Gemcitabine, Paclitaxel)

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • Bayeux, France
  • +25 more
May 17, 2022